[PDF][PDF] Expanding the Baveno VI criteria for the screening of varices in patients with compensated advanced chronic liver disease
S Augustin, M Pons, JB Maurice, C Bureau… - …, 2017 - Wiley Online Library
Patients with compensated advanced chronic liver disease (cACLD) can safely avoid
screening endoscopy with a platelet count> 150× 109 cells/L and a liver stiffness …
screening endoscopy with a platelet count> 150× 109 cells/L and a liver stiffness …
CHESS Criteria for Varices Screening in Compensated Advanced Chronic Liver Disease (CHESS2001/APPHA2001)
L Zhang, G Zhang, GZA Region - trialbulletin.com
Variceal hemorrhage is the serious complication in patients with compensated advanced
chronic liver disease (cACLD). To evaluate the bleeding risk of varices in cACLD …
chronic liver disease (cACLD). To evaluate the bleeding risk of varices in cACLD …
Baveno criteria safely identify patients with compensated advanced chronic liver disease who can avoid variceal screening endoscopy: a diagnostic test accuracy …
Background: The Baveno VI Consensus Workshop defined criteria (liver stiffness measured
by transient elastography< 20 kPa and platelet count> 150× 109 cells/L) to identify those …
by transient elastography< 20 kPa and platelet count> 150× 109 cells/L) to identify those …
Including ratio of platelets to liver stiffness improves accuracy of screening for esophageal varices that require treatment
Background & Aims Based on platelets and liver stiffness measurements, the Baveno VI
criteria (B6C), the expanded B6C (EB6C), and the ANTICIPATE score can be used to rule …
criteria (B6C), the expanded B6C (EB6C), and the ANTICIPATE score can be used to rule …
Deciding among noninvasive tools for predicting varices needing treatment in chronic liver disease: an analysis of Asian cohort
S Sharma, S Agarwal, D Gunjan… - Official journal of the …, 2020 - journals.lww.com
METHODS: Patients with compensated advanced CLD (cACLD) who underwent
esophagogastroduodenoscopy and TE within 3 months were included. Diagnostic …
esophagogastroduodenoscopy and TE within 3 months were included. Diagnostic …
A Novel Model for the Screening of Varices in Patients With Compensated Cirrhosis: An International Multicenter Study
C Liu, J Li, QL Zeng, H You, D Ji, YJ Wong, Y Gu… - papers.ssrn.com
Abstract Background and Aims: The Baveno VI and expanded-Baveno VI criteria has been
validated as single-use screening for varices needing treatment (VNT) in patients enriched …
validated as single-use screening for varices needing treatment (VNT) in patients enriched …
[HTML][HTML] Validation of original, expanded Baveno VI, and stepwise & platelet-MELD criteria to rule out varices needing treatment in compensated cirrhosis from various …
S Nawalerspanya, P Sripongpun, N Chamroonkul… - Annals of …, 2020 - Elsevier
Abstract Introduction and objectives The Baveno VI criteria to rule out varices needing
treatment (VNT) was introduced in 2015. Soon after, the expanded Baveno VI and stepwise …
treatment (VNT) was introduced in 2015. Soon after, the expanded Baveno VI and stepwise …
Evaluation of three “beyond Baveno VI” criteria to safely spare endoscopies in compensated advanced chronic liver disease
G Tosetti, M Primignani, V La Mura… - Digestive and Liver …, 2019 - Elsevier
Background Liver stiffness measurement (LSM)< 20 kPa and platelet count> 150,000/mm 3
exclude varices needing treatment (VNT) in viral compensated advanced chronic liver …
exclude varices needing treatment (VNT) in viral compensated advanced chronic liver …
Modified and alternative Baveno VI criteria based on age for ruling out high-risk varices in patients with compensated cirrhosis
L Zhao, T Wang, C Guo, L Zhou, P Han, C Wang… - Hepatology …, 2022 - Springer
Abstract Background The Baveno VI criteria (B6C) have been recommended to screen high-
risk varices (HRV) in patients with liver cirrhosis to avoid the use of …
risk varices (HRV) in patients with liver cirrhosis to avoid the use of …